← Scoopfeeds — Intelligent news, curated.
Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history.
business

Novo Nordisk says the Wegovy pill saw the fastest take-up in weight-loss drug history.

MarketWatch · May 6, 2026, 7:25 AM · Also reported by 4 other sources

Novo Nordisk on Wednesday narrowly improved its financial guidance for a year where it still sees profit and sales falling after the fastest take-up in weight-loss drug history for its Wegovy pill.

Read full story on MarketWatch → More top stories

Also covered by

CNBC Wegovy pill sales smash forecasts after launch as Novo Nordisk hikes guidance Bloomberg Markets Novo Raises Forecast as Wegovy Pill Fuels Sales Investing.com Novo Nordisk lifts 2026 outlook as Wegovy drives growth; shares surge Investing.com Novo Nordisk’s Q1 profit beats forecasts

More in business

CoinDesk
Crypto custodian Taurus moves straight into EU capital markets with MiFID license in Cyprus
Investing.com
France’s services sector contracts further in April, final PMI shows
Investing.com
Migros shares jump 5.8% on higher-than-expected Q1 profit
Investing.com
JCDecaux shares fall on Q2 sales growth outlook
Investing.com
Now up 187%+, a new list of AI-picked stocks for May IS LIVE - See it HERE
Aggregated and edited by the Scoop newsroom. We surface news from MarketWatch alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop